DCPT-1061

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameDCPT-1061
Drug Alias NameDCPT-1061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein arginine N-methyltransferase 1 inhibitors
TargetsProtein arginine N-methyltransferase 1
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiaotong University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A